At the end of June this year, following the spin-off from Respiratorius, trading in Arcede Pharma began on Spotlight. At the helm is CEO Mia Lundblad, who came to the BioStock Investor Meeting to talk about Arcede’s COPD and asthma project RCD45. She also talked about what’s next to come for the company.
Watch Arcede Pharma’s presentation below.The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.